Michael Nelboeck
Roche Diagnostics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Nelboeck.
Pharmacological Research Communications | 1974
Gerhard Michal; K. Mühlegger; Michael Nelboeck; C. Thiessen; Gunter Weimann
Summary The synthesis and the chemical and physical properties of a major number of 3′,5′-cyclophosphates is described. These compounds are derivatives of 3′,5′-AMP, 3′,5′-IMP or 3′,5′-GMP, substituted in the 6-, 8-, 2- or 2′-position. Furthermore, the partial purification of phosphodiesterase from beef pituitary is described. The cyclophosphate analogues were tested for their splitting behavior at mM substrate concentration with several different phosphodiesterases. Due to the heterogenicity of this enzyme, the selection of the proper reference compound for calculating the relative splitting rates is of importance. The patterns of splitting rate changes caused by different substituents are discussed. Based on additional measurements of the mutual inhibition behavior, some conclusions on the relationship of splitting rates and inhibition effects are drawn.
Biochimica et Biophysica Acta | 1971
Marianne Plooy; Gerhard Michal; Guenther Weimann; Michael Nelboeck; Rodolfo Paoletti
Abstract 1. 1. The influence of various cyclophates on phosphorylase b kinase activation was tested in a liver extract and purified muscle protein fraction. 2. 2. The compounds showed a maximum acceleration of activation within 90–113% of that caused by adenosine 3′,5′-monophosphate (3′,5′-AMP); the concentration range in which this acceleration took place different from compound to compound. 3. 3. Substitution in the 6-position of the purine moiety does not influence the activation reaction greatly. Some compounds are even active in lower concentration than 3′,5′-AMP. 8-Substituted derivatives of 3′,5′-AMP require slightly higher concentrations for activation, the corresponding derivatives of 3′,5′-APM need about a 10-fold concentration. Pyrimidine derivatives require about a 50-fold concentration, molecules with altered 2′-position about a 100-fold concentration. The shifts are multiplicative. 4. 4. Comparison of results show that activation in the liver system is observed at lower cyclophosphate concentrations than in the muscle system. 5. 5. The biochemical implications of the results are discussed.
Pharmacological Research Communications | 1973
Rodolfo Paoletti; F. Berti; PierFranco Spano; Gerhard Michal; G. Weimann; Michael Nelboeck
Summary New synthetic derivatives of natural cyclic nucleotides have been tested for their metabolic (blood glucose and plasma corticosterone) and cardiovascular (heart rate and blood pressure) effects in the rat. A clear cut specificity of the effects emerges from the comparison between the different series of substituted nucleotides (N 6 , 2′O-8-and 2-substitutions). A long lasting effect on plasma steroid levels has been demonstrated with the compound 6-(3′4′-dimethoxyphenyl-)ethyl-amino-3′,5′-PuMP + , at doses and times where there is no effect on the cardiovascular parameters or blood glucose levels.
Pure and Applied Chemistry | 1973
Michael Nelboeck; Gerhard Michal; G. Weimann; Rodolfo Paoletti; F. Berti
ABSTRACT Sutherlands second messenger model and the intracellular cAMP†-system is presented. The key-points of its manipulation by externally applied compounds are discussed. They form the guidelines for development of chemical analogues of the cAMP molecule effective on phosphodiesterases and protein kinases. Special attention is devoted to their influence on glycogenolysis, steroidogenesis, lipolysis, hormone secretion and contractility of various muscles. Some of these analogues show relatively high specificity of physiological responses, such as separation of metabolic and contractile effects, while others show general enhancement of the multivalent responses of cAMP itself. It is shown that a good correlation between in vitro and in vivo data exist. The pharmacological significance of these findings is briefly discussed.
Archive | 1983
Ernst Homann; Michael Nelboeck; Klaus Schlieder; Gernold Bayer
Archive | 1980
Klaus Beaucamp; Michael Nelboeck; Helmgard Gauhl; Hans Seidel; Wolfgang Gruber; Herwig Brunner
Archive | 1980
Klaus Beaucamp; Michael Nelboeck; Helmgard Gauhl; Hans Seidel; Wolfgang Gruber; Herwig Brunner
Archive | 1980
Klaus Beaucamp; Michael Nelboeck; Helmgard Gauhl; Hans Seidel; Wolfgang Gruber; Herwig Brunner
Archive | 1981
Klaus Beaucamp; Michael Nelboeck; Helmgard Gauhl; Hans Seidel; Wolfgang Gruber; Herwig Brunner
Archive | 1983
Ernst Homann; Michael Nelboeck; Klaus Schlieder; Gernold Bayer